[1]
R. Fischer, “Microbiome Alterations as Predictive Biomarkers for Immunotherapy Response in Non-Small Cell Lung Cancer”, Med. Insights, vol. 2, no. 2, pp. 49–61, Jun. 2025, doi: 10.70088/4z7rrk95.